APO Research
Talk to an analyst

APO RESEARCH · REPORT

Advanced Therapeutics Pharmaceutical Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook and Growth Opportunities 2026

2 May 2026192 pages

Choose your research edition.

Industry ResearchAdvanced Therapeutics Pharmaceutical Outsourcing Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Advanced Therapeutics Pharmaceutical Outsourcing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Advanced Therapeutics Pharmaceutical Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Advanced Therapeutics Pharmaceutical Outsourcing Market Analysis and Forecast 2026-2032228 pages · $4,950 USD

Market perspective

The global Advanced Therapeutics Pharmaceutical Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Advanced Therapeutics Pharmaceutical Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Advanced Therapeutics Pharmaceutical Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Advanced Therapeutics Pharmaceutical Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Advanced Therapeutics Pharmaceutical Outsourcing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Advanced Therapeutics Pharmaceutical Outsourcing market include Croda International Plc, Charles River Laboratories International, Inc., Catalent, Inc., QuintileslMS (IQVIA), Parexel International Corporation, ICON plc, PPD, Inc. (Thermo Fisher Scientific), LabCorp (Laboratory Corporation of America Holdings) and Syneos Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Advanced Therapeutics Pharmaceutical Outsourcing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Advanced Therapeutics Pharmaceutical Outsourcing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Advanced Therapeutics Pharmaceutical Outsourcing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Advanced Therapeutics Pharmaceutical Outsourcing market.

Advanced Therapeutics Pharmaceutical Outsourcing Segment by Company

Croda International Plc

Charles River Laboratories International, Inc.

Catalent, Inc.

QuintileslMS (IQVIA)

Parexel International Corporation

ICON plc

PPD, Inc. (Thermo Fisher Scientific)

LabCorp (Laboratory Corporation of America Holdings)

Syneos Health

wuXi AppTecLonza Group

Piramal Pharma Solutions

SGS SA

Evotec SE

CMC Biologics (Now AGC Biologics)

Marken (A UPS Company)

Cytovance Biologics

Samsung Biologics

Advanced Therapeutics Pharmaceutical Outsourcing Segment by Type

Contract Research Organizations (CROs)

Contract Development and Manufacturing Organizations (CDMOs)

Advanced Therapeutics Pharmaceutical Outsourcing Segment by Application

Preclinical Services

Clinical Services

Commercial Manufacturing and Packaging

Advanced Therapeutics Pharmaceutical Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Advanced Therapeutics Pharmaceutical Outsourcing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Advanced Therapeutics Pharmaceutical Outsourcing key companies, revenue, market share, and recent developments.

3. To split the Advanced Therapeutics Pharmaceutical Outsourcing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Advanced Therapeutics Pharmaceutical Outsourcing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Advanced Therapeutics Pharmaceutical Outsourcing significant trends, drivers, influence factors in global and regions.

6. To analyze Advanced Therapeutics Pharmaceutical Outsourcing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapeutics Pharmaceutical Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapeutics Pharmaceutical Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapeutics Pharmaceutical Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Advanced Therapeutics Pharmaceutical Outsourcing industry.

Chapter 3: Detailed analysis of Advanced Therapeutics Pharmaceutical Outsourcing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Advanced Therapeutics Pharmaceutical Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Advanced Therapeutics Pharmaceutical Outsourcing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Advanced Therapeutics Pharmaceutical Outsourcing Industry Trends Table 2. Advanced Therapeutics Pharmaceutical Outsourcing Industry Drivers Table 3. Advanced Therapeutics Pharmaceutical Outsourcing Industry Opportunities and Challenges Table 4. Advanced Therapeutics Pharmaceutical Outsourcing Industry Restraints Table 5. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Company (2021-2026) Table 7. Global Advanced Therapeutics Pharmaceutical Outsourcing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Advanced Therapeutics Pharmaceutical Outsourcing Key Company Manufacturing Base & Headquarters Table 9. Global Advanced Therapeutics Pharmaceutical Outsourcing Company, Product Type & Application Table 10. Global Advanced Therapeutics Pharmaceutical Outsourcing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Advanced Therapeutics Pharmaceutical Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Contract Research Organizations (CROs) Table 15. Significant Companies of Contract Development and Manufacturing Organizations (CDMOs) Table 16. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type (2021-2026) Table 20. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Preclinical Services Table 22. Significant Companies of Clinical Services Table 23. Significant Companies of Commercial Manufacturing and Packaging Table 24. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application (2021-2026) Table 28. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application (2027-2032) Table 29. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Region (2021-2026) Table 32. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Region (2027-2032) Table 34. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Market Share by Country (2021-2026) Table 37. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Market Share by Country (2027-2032) Table 39. Croda International Plc Company Information Table 40. Croda International Plc Business Overview Table 41. Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 43. Croda International Plc Recent Development Table 44. Charles River Laboratories International, Inc. Company Information Table 45. Charles River Laboratories International, Inc. Business Overview Table 46. Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 48. Charles River Laboratories International, Inc. Recent Development Table 49. Catalent, Inc. Company Information Table 50. Catalent, Inc. Business Overview Table 51. Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 53. Catalent, Inc. Recent Development Table 54. QuintileslMS (IQVIA) Company Information Table 55. QuintileslMS (IQVIA) Business Overview Table 56. QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 58. QuintileslMS (IQVIA) Recent Development Table 59. Parexel International Corporation Company Information Table 60. Parexel International Corporation Business Overview Table 61. Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 63. Parexel International Corporation Recent Development Table 64. ICON plc Company Information Table 65. ICON plc Business Overview Table 66. ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 68. ICON plc Recent Development Table 69. PPD, Inc. (Thermo Fisher Scientific) Company Information Table 70. PPD, Inc. (Thermo Fisher Scientific) Business Overview Table 71. PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 73. PPD, Inc. (Thermo Fisher Scientific) Recent Development Table 74. LabCorp (Laboratory Corporation of America Holdings) Company Information Table 75. LabCorp (Laboratory Corporation of America Holdings) Business Overview Table 76. LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 78. LabCorp (Laboratory Corporation of America Holdings) Recent Development Table 79. Syneos Health Company Information Table 80. Syneos Health Business Overview Table 81. Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 83. Syneos Health Recent Development Table 84. wuXi AppTecLonza Group Company Information Table 85. wuXi AppTecLonza Group Business Overview Table 86. wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 88. wuXi AppTecLonza Group Recent Development Table 89. Piramal Pharma Solutions Company Information Table 90. Piramal Pharma Solutions Business Overview Table 91. Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 93. Piramal Pharma Solutions Recent Development Table 94. SGS SA Company Information Table 95. SGS SA Business Overview Table 96. SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 98. SGS SA Recent Development Table 99. Evotec SE Company Information Table 100. Evotec SE Business Overview Table 101. Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 103. Evotec SE Recent Development Table 104. CMC Biologics (Now AGC Biologics) Company Information Table 105. CMC Biologics (Now AGC Biologics) Business Overview Table 106. CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 108. CMC Biologics (Now AGC Biologics) Recent Development Table 109. Marken (A UPS Company) Company Information Table 110. Marken (A UPS Company) Business Overview Table 111. Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 113. Marken (A UPS Company) Recent Development Table 114. Cytovance Biologics Company Information Table 115. Cytovance Biologics Business Overview Table 116. Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 118. Cytovance Biologics Recent Development Table 119. Samsung Biologics Company Information Table 120. Samsung Biologics Business Overview Table 121. Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 123. Samsung Biologics Recent Development Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Advanced Therapeutics Pharmaceutical Outsourcing Product Image Figure 2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size (2021-2032) & (US$ Million) Figure 4. Global Advanced Therapeutics Pharmaceutical Outsourcing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Contract Research Organizations (CROs) Image Figure 8. Contract Development and Manufacturing Organizations (CDMOs) Image Figure 9. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type (2021-2032) Figure 12. Preclinical Services Image Figure 13. Clinical Services Image Figure 14. Commercial Manufacturing and Packaging Image Figure 15. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application (2021-2032) Figure 18. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
Applications
  • Preclinical Services
  • Clinical Services
  • Commercial Manufacturing and Packaging
Companies covered
  • Croda International Plc
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.
  • QuintileslMS (IQVIA)
  • Parexel International Corporation
  • ICON plc
  • PPD, Inc. (Thermo Fisher Scientific)
  • LabCorp (Laboratory Corporation of America Holdings)
  • Syneos Health
  • wuXi AppTecLonza Group
  • Piramal Pharma Solutions
  • SGS SA
  • Evotec SE
  • CMC Biologics (Now AGC Biologics)
  • Marken (A UPS Company)
  • Cytovance Biologics
  • Samsung Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Advanced Therapeutics Pharmaceutical Outsourcing Market Dynamics
  1. 2.1 Advanced Therapeutics Pharmaceutical Outsourcing Industry Trends
  2. 2.2 Advanced Therapeutics Pharmaceutical Outsourcing Industry Drivers
  3. 2.3 Advanced Therapeutics Pharmaceutical Outsourcing Industry Opportunities and Challenges
  4. 2.4 Advanced Therapeutics Pharmaceutical Outsourcing Industry Restraints
3 Advanced Therapeutics Pharmaceutical Outsourcing Market by Company
  1. 3.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Company Revenue Ranking in 2025
  2. 3.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Company (2021-2026)
  3. 3.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Company Ranking (2024-2026)
  4. 3.4 Global Advanced Therapeutics Pharmaceutical Outsourcing Company Manufacturing Base and Headquarters
  5. 3.5 Global Advanced Therapeutics Pharmaceutical Outsourcing Company Product Type and Application
  6. 3.6 Global Advanced Therapeutics Pharmaceutical Outsourcing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Advanced Therapeutics Pharmaceutical Outsourcing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Advanced Therapeutics Pharmaceutical Outsourcing Market by Type
  1. 4.1 Advanced Therapeutics Pharmaceutical Outsourcing Type Introduction
  2. 4.1.1 Contract Research Organizations (CROs)
  3. 4.1.2 Contract Development and Manufacturing Organizations (CDMOs)
  4. 4.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Type
  5. 4.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type (2021-2032)
5 Advanced Therapeutics Pharmaceutical Outsourcing Market by Application
  1. 5.1 Advanced Therapeutics Pharmaceutical Outsourcing Application Introduction
  2. 5.1.1 Preclinical Services
  3. 5.1.2 Clinical Services
  4. 5.1.3 Commercial Manufacturing and Packaging
  5. 5.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Application
  6. 5.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application (2021-2032)
6 Advanced Therapeutics Pharmaceutical Outsourcing Regional Value Analysis
  1. 6.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032)
  7. 6.3.2 North America Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032)
  10. 6.4.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032)
  16. 6.6.2 South America Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Country, 2025 VS 2032
7 Advanced Therapeutics Pharmaceutical Outsourcing Country-level Value Analysis
  1. 7.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Advanced Therapeutics Pharmaceutical Outsourcing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Croda International Plc
  2. 8.1.1 Croda International Plc Company Information
  3. 8.1.2 Croda International Plc Business Overview
  4. 8.1.3 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  6. 8.1.5 Croda International Plc Recent Developments
  7. 8.2 Charles River Laboratories International, Inc.
  8. 8.2.1 Charles River Laboratories International, Inc. Company Information
  9. 8.2.2 Charles River Laboratories International, Inc. Business Overview
  10. 8.2.3 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  12. 8.2.5 Charles River Laboratories International, Inc. Recent Developments
  13. 8.3 Catalent, Inc.
  14. 8.3.1 Catalent, Inc. Company Information
  15. 8.3.2 Catalent, Inc. Business Overview
  16. 8.3.3 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  18. 8.3.5 Catalent, Inc. Recent Developments
  19. 8.4 QuintileslMS (IQVIA)
  20. 8.4.1 QuintileslMS (IQVIA) Company Information
  21. 8.4.2 QuintileslMS (IQVIA) Business Overview
  22. 8.4.3 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  24. 8.4.5 QuintileslMS (IQVIA) Recent Developments
  25. 8.5 Parexel International Corporation
  26. 8.5.1 Parexel International Corporation Company Information
  27. 8.5.2 Parexel International Corporation Business Overview
  28. 8.5.3 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  30. 8.5.5 Parexel International Corporation Recent Developments
  31. 8.6 ICON plc
  32. 8.6.1 ICON plc Company Information
  33. 8.6.2 ICON plc Business Overview
  34. 8.6.3 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  36. 8.6.5 ICON plc Recent Developments
  37. 8.7 PPD, Inc. (Thermo Fisher Scientific)
  38. 8.7.1 PPD, Inc. (Thermo Fisher Scientific) Company Information
  39. 8.7.2 PPD, Inc. (Thermo Fisher Scientific) Business Overview
  40. 8.7.3 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  42. 8.7.5 PPD, Inc. (Thermo Fisher Scientific) Recent Developments
  43. 8.8 LabCorp (Laboratory Corporation of America Holdings)
  44. 8.8.1 LabCorp (Laboratory Corporation of America Holdings) Company Information
  45. 8.8.2 LabCorp (Laboratory Corporation of America Holdings) Business Overview
  46. 8.8.3 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  48. 8.8.5 LabCorp (Laboratory Corporation of America Holdings) Recent Developments
  49. 8.9 Syneos Health
  50. 8.9.1 Syneos Health Company Information
  51. 8.9.2 Syneos Health Business Overview
  52. 8.9.3 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  54. 8.9.5 Syneos Health Recent Developments
  55. 8.10 wuXi AppTecLonza Group
  56. 8.10.1 wuXi AppTecLonza Group Company Information
  57. 8.10.2 wuXi AppTecLonza Group Business Overview
  58. 8.10.3 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  60. 8.10.5 wuXi AppTecLonza Group Recent Developments
  61. 8.11 Piramal Pharma Solutions
  62. 8.11.1 Piramal Pharma Solutions Company Information
  63. 8.11.2 Piramal Pharma Solutions Business Overview
  64. 8.11.3 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  66. 8.11.5 Piramal Pharma Solutions Recent Developments
  67. 8.12 SGS SA
  68. 8.12.1 SGS SA Company Information
  69. 8.12.2 SGS SA Business Overview
  70. 8.12.3 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  72. 8.12.5 SGS SA Recent Developments
  73. 8.13 Evotec SE
  74. 8.13.1 Evotec SE Company Information
  75. 8.13.2 Evotec SE Business Overview
  76. 8.13.3 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  78. 8.13.5 Evotec SE Recent Developments
  79. 8.14 CMC Biologics (Now AGC Biologics)
  80. 8.14.1 CMC Biologics (Now AGC Biologics) Company Information
  81. 8.14.2 CMC Biologics (Now AGC Biologics) Business Overview
  82. 8.14.3 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  84. 8.14.5 CMC Biologics (Now AGC Biologics) Recent Developments
  85. 8.15 Marken (A UPS Company)
  86. 8.15.1 Marken (A UPS Company) Company Information
  87. 8.15.2 Marken (A UPS Company) Business Overview
  88. 8.15.3 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  90. 8.15.5 Marken (A UPS Company) Recent Developments
  91. 8.16 Cytovance Biologics
  92. 8.16.1 Cytovance Biologics Company Information
  93. 8.16.2 Cytovance Biologics Business Overview
  94. 8.16.3 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  96. 8.16.5 Cytovance Biologics Recent Developments
  97. 8.17 Samsung Biologics
  98. 8.17.1 Samsung Biologics Company Information
  99. 8.17.2 Samsung Biologics Business Overview
  100. 8.17.3 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  102. 8.17.5 Samsung Biologics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst